Treatment of therapy-resistant pemphigus vulgaris with rituximab and immunoglobulins;Behandlung eines therapieresistenten pemphigus vulgaris mit rituximab und immunglobulinen

Hautarzt

Volumn 58, Issue 11, 2007, Pages 924-926

  Muhlhoff C ^a   Megahed, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DAPSONE; DESMOGLEIN; FUSIDATE SODIUM; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADULT; BLISTER; CASE REPORT; CONFERENCE PAPER; EOSINOPHIL COUNT; EROSION; HUMAN; HYPERPIGMENTATION; IMMUNOFLUORESCENCE TEST; MALE; NEUTROPHIL COUNT; PEMPHIGUS VULGARIS; SKIN EXAMINATION;

ADULT; ANTIBODIES, MONOCLONAL; CLINICAL PROTOCOLS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; PEMPHIGUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 36049038935     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1414-x     Document Type: Conference Paper

References (11)

1. Ahmed AR, Spigelman Z, Cavacini LA, Posner MR (2006) Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 355: 1772-1779
2. Bermudez A, Marco F, Conde E et al. (2000) Fatal varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica 85: 894-895
3. Bystryn JC, Steinmann NM (1996) The adjuvant therapy of pemphigus: an update. Arch Dermatol 132: 203-212
4. Dupuy A, Viguier M, Bedane C et al. (2004) Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol 140: 91-96
5. El Tal Ak, Posner MR, Spigelman Z, Ahmed AR (2006) Rituximab: a monoklonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 55: 449-459
6. Hoyer BF, Manz RA, Radbruch A, Hiepe F (2005) Long-lived plasma cells and their contribution to autoimmunity. Ann N Y Acad Sci 1050: 124-133
7. Joly P, Mouquet H, Roujeau JC et al. (2007) A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 357: 545-552
8. Lernbecher T (2001) Intravenous immunglobulins in the prevention of infection in children with mematologic-oncologic diseases. Klin Padiatr 213 (Suppl 1): A103-A105
9. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176: 705-710
10. Quartier P, Tournilhac O, Archimbaud C et al. (2003) Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis 36: e47-e49
11. Sullivan KM, Kopecky KJ, Jocom J et al. (1990) Immunomodulatory and antimicrobial efficiacy of intravenous immunoglobulin in bone marrow transplantation. Oncogene 22: 7359-7368